HA Sustainable Infrastructure Capital vs National Health Investors
HASI and NHI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HASI and NHI compare
HA Sustainable Infrastructure Capital is the larger company, worth 1.7 times as much as National Health Investors ($4.9B against $2.9B).
On earnings, National Health Investors is cheaper: it trades at 17.3× trailing earnings, against 66.7× for HA Sustainable Infrastructure Capital.
HA Sustainable Infrastructure Capital grew revenue faster over the last twelve months (26.5% versus 23.9% for National Health Investors).
National Health Investors keeps more of each dollar of sales as profit, with a net margin of 38.6% compared with 18.6% at HA Sustainable Infrastructure Capital.
Both pay dividends: HA Sustainable Infrastructure Capital yields 4.5% and National Health Investors 6.2%.
National Health Investors scores higher on the StockData Score (14 against 9 for HA Sustainable Infrastructure Capital), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HASI | NHI |
|---|---|---|
| Size and price | ||
| Market cap | $4.9B | $2.9B |
| Share price | $38.01 | $59.98 |
| Change, 1 year | 13.0% | −22.3% |
| Change, 5 years | −33.4% | 13.7% |
| Beta (5Y) | 0.55 | −0.49 |
| Employees | 178 | 32 |
| StockData Score | ||
| Total score | 9 | 14 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 4 | 5 (better) |
| Performance score | 2 | 3 (better) |
| Health score | 1 (better) | 0 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 66.7× | 17.3× (better) |
| P/S | 10.6× | 6.8× (better) |
| P/B | – | 1.9× |
| EV/EBITDA | 10.0× | – |
| PEG | 1.51 | 0.65 (better) |
| Fair value | $23.08 | $70.31 |
| Margin of safety | −64.7% | 14.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 26.5% (better) | 23.9% |
| Revenue growth, 5Y average | 16.5% (better) | 2.5% |
| Net income growth (TTM) | −58.1% | 16.7% (better) |
| EPS growth (TTM) | −62.7% | 10.5% (better) |
| EPS growth, 5Y average | 5.1% (better) | −6.1% |
| Profitability | ||
| Net margin | 18.6% | 38.6% (better) |
| Return on equity | – | 10.9% |
| Financial health | ||
| Net debt / EBITDA | −0.53 | – |
| Altman Z-score | 0.46 | 2.77 (better) |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 4.5% | 6.2% (better) |
| Payout ratio | 255% | 105% |
| Years of dividend growth | – | 1 |
| Dividend growth, 5Y average | – | −4.6% |
| Buyback yield | −2.4% (better) | −3.5% |
| Shareholder yield | 2.1% | 2.7% (better) |
| Ownership | ||
| Held by institutions | 103% | 77.7% |
| Held by insiders | 0.72% | 2.5% |
| Insider net buying, 12 months | −$5.3M | $167K (better) |
| Short interest, % of float | 11.6% | 4.6% |
Go deeper
- HASI stock overview
- HASI income statement
- HASI valuation and score
- NHI stock overview
- NHI income statement
- NHI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.